Tatva Chintan Pharma Chem News
- Market cap
- ₹4,194 crore
- P/E
- 22.5
- P/B
- 2.85
- ROE
- 14.5%
- Dividend yield
- 1.20%
- 52-week range
- ₹1,290.82 – ₹2,420.28
The latest update on Tatva Chintan Pharma Chem is "Tatva Chintan Pharma Chem Limited Reports Operational Performance & Quarterly Growth Update" (BSE Corporate Announcement), published 9 October 2026. This page lists 4 recent headlines and exchange announcements, 2 of them filed on BSE. Tatva Chintan Pharma Chem's next board meeting for results is scheduled for 3 November 2026.
Latest Tatva Chintan Pharma Chem news and announcements
Next results board meeting: 3 November 2026.
- Tatva Chintan Pharma Chem Limited Reports Operational Performance & Quarterly Growth Update
- Market Activity: Tatva Chintan Pharma Chem Limited Shares See Strong Institutional Volume
- Tatva Chintan Pharma Chem Limited Board Compliances & Mandatory Disclosure Filings Submitted
- Analyst Review: Key Valuation Overview & Target Projection for Tatva Chintan Pharma Chem Limited
Source: Publisher headlines and announcements filed on BSE, linked to their original sources. Data as of 9 October 2026. How this data is compiled.
Tatva Chintan Pharma Chem news & announcements — frequently asked questions
What is the latest news on Tatva Chintan Pharma Chem?
The most recent item is "Tatva Chintan Pharma Chem Limited Reports Operational Performance & Quarterly Growth Update" from BSE Corporate Announcement on 9 October 2026. The full list above links to each original source.
When are Tatva Chintan Pharma Chem's next results?
Tatva Chintan Pharma Chem has announced a board meeting on 3 November 2026 to consider its financial results, according to its filing on BSE.
Where do these Tatva Chintan Pharma Chem headlines come from?
Headlines link to the original publisher, and exchange announcements link to the filing on BSE. ATS lists them by date and does not rewrite or summarise them.
Same Data For Peers
- Themis Medicare Limited news & announcements
- Syngene International Limited news & announcements
- Thyrocare Technologies Limited news & announcements
- Syncom Formulations (India) Limited news & announcements
- Torrent Pharmaceuticals Limited news & announcements
- Suven Life Sciences Limited news & announcements
Trade Tatva Chintan Pharma Chem With ATS
Track TATVA live and place orders from the Pocket app or the Pocket Web terminal with an ATS trading and demat account.
Figures are for information only and are not investment advice or a recommendation to buy, sell or hold any security. Investments in securities are subject to market risks; read all related documents carefully before investing.